# Combination of Haloperidol and Magnesium for Delirium Prevention in Critically Ill Elderly

> **NCT06168773** · PHASE2,PHASE3 · COMPLETED · sponsor: **Ain Shams University** · enrollment: 135 (actual)

## Conditions studied

- Delirium in Old Age

## Interventions

- **DRUG:** Haloperidol Injection

## Key facts

- **NCT ID:** NCT06168773
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-01
- **Primary completion:** 2023-10-24
- **Final completion:** 2023-11-04
- **Target enrollment:** 135 (ACTUAL)
- **Last updated:** 2023-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06168773

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06168773, "Combination of Haloperidol and Magnesium for Delirium Prevention in Critically Ill Elderly". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06168773. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*